Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction in shoulder arthroplasty
ACTRN12616000723482Phase 4Completed
- Sponsor
- Dr Benjamin Cass
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in shoulder arthritis comparing Tranexamic acid with Placebo saline control (2 arms). Primary endpoints: Change in haemoglobin level and Change in haematocrit. Started Oct 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
shoulder arthritis
Beyond the preview
Go deeper on ACTRN12616000723482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000723482.